NCT06979596: A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
- State
- Under way
- Phase
- Phase 2
- People
- 250 planned
- Started
- 11 Aug 2025
- Primary completion
- 4 Nov 2027
- Arms
- Fulvestrant or Exemestane
- Results
- None posted
- 20 May 2025: Trial registered
- 11 Aug 2025: Trial started